# Roivant Sciences Ltd. (ROIV)

> Healthcare · GB · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ROIV/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 13.63M | $ -828.59M | $ -513.47M | $ 207.44M | $ 4.27B |
| 2024 | $ 32.06M | $ -122.58M | $ -3.79B | $ 100.31M | $ 5.19B |
| 2023 | $ 73.75M | $ 4.83B | $ 4.84B | $ 506.58M | $ 6.09B |
| 2022 | $ 19.05M | $ -393.24M | $ -252.58M | $ 479.64M | $ 955.52M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.05 |
| Liabilities / Eq | 0.06 |
| Current Ratio | 30.66 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.24 |
| Gross Debt / FCF | 2.98 |

## Other views

- [Metrics](https://sponda.capital/en/ROIV.md)
- [Charts](https://sponda.capital/en/ROIV/charts.md)
- [Compare](https://sponda.capital/en/ROIV/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.